Incidence of sexually transmitted infections among HIV-infected women using depot medroxyprogesterone acetate contraception

Contraception

Volumn 78, Issue 2, 2008, Pages 125-130

  Overton, Edgar Turner ^a   Shacham, Enbal ^a   Singhatiraj, Ekachai ^a   Nurutdinova, Diana ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

DMPA; HIV; Hormonal contraception; STI; Women

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CHLAMYDIASIS; COHORT ANALYSIS; CONDOM; CONTRACEPTION; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GONORRHEA; HIGH RISK BEHAVIOR; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTPATIENT DEPARTMENT; PATIENT IDENTIFICATION; POPULATION; RETROSPECTIVE STUDY; SELF REPORT; SEXUALLY TRANSMITTED DISEASE; SUBSTANCE ABUSE; TRICHOMONIASIS; UNIVERSITY;

ADULT; COHORT STUDIES; CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MEDROXYPROGESTERONE 17-ACETATE; RETROSPECTIVE STUDIES; SEXUALLY TRANSMITTED DISEASES;

EID: 47849109032     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2008.03.015     Document Type: Article

References (30)

1. Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005 Vol. 17 (2006), U.S. Department of Health and Human Services, CDC, Atlanta 1-46. http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/default.htm Accessed June 5, 2007
2. Bersoff-Matcha S.J., Horgan M.M., Fraser V.J., et al. Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis 178 (1998) 1174-1177
3. van Benthem B.H., Prins M., Larsen C., et al. Sexually transmitted infections in European HIV-infected women: incidence in relation to time from infection. European Study on the Natural History of HIV Infection in Women. AIDS 14 (2000) 595-603
4. Connolly C.A., Ramjee G., Sturm A.W., and Abdool Karim S.S. Incidence of sexually transmitted infections among HIV-positive sex workers in KwaZulu-Natal, South Africa. Sex Transm Dis 29 (2002) 721-724
5. Erbelding E.J., Chung S., and Zenilman J.M. New sexually transmitted diseases in HIV-infected patients: markers for ongoing HIV transmission behavior. J Acquir Immune Defic Syndr 33 (2003) 247-252
6. McClelland R.S., Lavreys L., Katingima C., et al. Contribution of HIV-1 infection to acquisition of sexually transmitted disease: a 10-year prospective study. J Infect Dis 191 (2005) 333-338
7. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 52 (2003) 1-17
8. Janssen R.S., Holtgrave D.R., Valdiserri R.O., et al. HIV epidemic: prevention strategies for infected individuals. Am J Public Health 91 (2001) 1019-1024
9. Wasserheit J.N. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 19 (1992) 61-77
10. Mitchell H.S., and Stephens E. Contraceptive choice for HIV positive women. Sex Transm Infect 80 (2004) 167-173
11. Stanwood N.L., Cohn S.E., Heiser J.R., et al. Contraception and fertility plans in a cohort of HIV-positive women in care. Contraception 75 (2007) 294-298
12. Louv W.C., Austin H., Perlman J., et al. Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol 160 (1989) 396-402
13. Clark R.A., Kissinger P., and Williams T. Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus. Int J STD AIDS 7 (1996) 439-442
14. Lavreys L., Chohan V., Overbauhg J., et al. Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women. AIDS 18 (2004) 2179-2184
15. Jacobson D.L., Peralta L., Farmer M., et al. Relationship of hormonal contraception and cervical ectopy as measured by computerized planimetry to chlamydial infection in adolescents. Sex Transm Dis 27 (2000) 313-319
16. Baeten J.M., Nyange P.M., Richardson B.A., et al. Hormonal contraception and risk of sexually transmitted disease acquisition: results from a prospective study. Am J Obstet Gynecol 185 (2001) 380-385
17. Morrison C.S., Bright P., Wong E.L., et al. Hormonal contraceptive use, cervical ectopy, and the acquisition of cervical infections. Sex Transm Dis 31 (2004) 561-567
18. Ghanem K., Johnson R., Koumans E., et al. Cervical specimen order and performance measures of Chlamydia trachomatis diagnostic testing. J Clin Microbiol 43 (2005) 5295-5297
19. Zeeberg B., Miorner H., Thelin I., et al. Comparison of strand displacement and ligase chain amplification for detection of Chlamydia trachomatis infection in urogenital specimens. Clin Microbiol Infect 11 (2005) 759-764
20. Wiese W., Patel S.R., Patel S.C., et al. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med 108 (2000) 301-308
21. Solomon D., Davey D., Kurman R., et al., Forum Group Members, Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 287 (2002) 2114-2119
22. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 1-94
23. Lavreys L., Baeten J.M., Martin Jr. H.L., et al. Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study. AIDS 18 (2004) 695-697
24. Baeten J.M., Benki S., Chohan V., et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 21 (2007) 1771-1777
25. Morrison C.S., Richardson B.A., Mmiro F., et al. Hormonal contraception and the risk of HIV acquisition. AIDS 21 (2007) 85-95
26. Tuffrey M., and Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol Lett 12 (1981) 111-115
27. Kauchic C., Zhou F., Murdin A.D., and Wira C.R. Effects of estradiol and progesterone on susceptibility and early immune responses to Chlamydia trachomatis infection in the female reproductive tract. Infect Immun 68 (2000) 4207-4216
28. Marx P.A., Spira A.I., Gettie A., et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 2 (1996) 1084-1089
29. Mauck C.K., Callahan M.M., Baker J., et al. The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 60 (1999) 15-24
30. Schroder K.E., Carey M.P., and Vanable P.A. Methodological challenges in research on sexual risk behavior: I. Item content, scaling, and data analytical options. Ann Behav Med 26 (2003) 76-103